In lung cancer patients, the association with blood NK cell activity through interferon-γ measurement and PD-1/PD-L1 inhibitor efficacy could be explained by induction of NK antibody-dependent cell cytotoxicity [33,34]. The gene discussed is CD274; the disease is lung cancer.